Contracts › 75N93019C00052
75N93019C00052: Component a of the Collaborative Influenza Vaccine Innovation Centers (CIVICS) Program to Design and Evaluate Innovative Influenza Vaccine Approaches, Based on Principles of Influenza Immunity, That Achieve Durable, Robust and Broadly Protective Immu
Awarded to University of Georgia Research Foundation, Inc. by National Institutes of Health (NIH).
$76.8Mobligated
$118.1Mpotential value
09 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93019C00052 |
|---|---|
| Awardee | University of Georgia Research Foundation, Inc. |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | GA |
| Offers received | 9 |
| Period of performance | 10 September 2019 to 09 September 2027 |
| Potential end | 09 September 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record